ArticleCureus2025
Platelet-Rich Plasma Plus Microneedling for Scar Management: Introduction to an Innovative Technique and Initial Results From 107 Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microneedling and Topical Retinyl Palmitate for Acne Scars: A Preliminary Split-Face Study with Placebo Control.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Scars are known to negatively impact patients' quality of life or even disable them. A broad spectrum of different scar treatments is used in clinical practice. Platelet-rich plasma (PRP) and microneedling are promising treatments that enhance tissue regeneration. The aim of this study was to evaluate the safety, clinical effects, and patients' experience of a combination treatment consisting of a series of PRP plus microneedling. Methods One hundred seven patients with scars, with various etiology and scar age, were included in our study. PRP had been prepared using the ACP double syringe system and was injected with high pressure into the dermis of the affected tissue, using the U225 meso injector as an injection and microneedling device. This treatment was applied three times at four-week intervals. On the days of treatment and at the 4-week follow-up, patient records were collected and clinical investigations and interviews were performed to assess clinical effects, adverse effects, and patient's experience. Results The results of this retrospective study indicate that 23 patients (21.5%) reported softer and more elastic scar tissue, 8 patients (7.5%) experienced improved mobility and functionality, 6 patients (5.6%) showed an overall healthier skin appearance, and 8 (7.5%) patients observed an improvement in color. Adverse effects reported were mild and only temporary. Twenty-three (21.5%) patients felt stressed before the treatment, and 12 patients (11.2%) reported tenderness during the first treatment of which two rated it as mildly painful. After the first treatment, two patients (1.9%) reported transient itchiness. Serious adverse effects did not occur. Conclusions PRP plus microneedling can enhance the pliability, mobility, and color of different scar types and scar ages. Overall, the treatment was easily feasible, well-tolerated and safe. Therefore, it can be considered a promising new treatment modality for scar management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.